A checklist will not replace a licensed clinician, but it will keep a first visit from turning into a vague yes. People considering a multi-agent metabolic plan often arrive with a brand tab still open. Use that tab as a source of names, then work through the items below. Educational pages about metformin and naltrexone are most helpful when they push you toward documentation rather than toward a one-click refill.
Before the appointment
Write your current medications, including as-needed opioids, sleep aids, and supplements. Add recent labs if you have them, especially kidney function and glucose markers. Note surgeries in the next 90 days. If you drink alcohol regularly or are trying to cut down, write that too — it changes how naltrexone is discussed.
Also write the outcome you actually want. Smaller clothes, better glucose, less evening grazing, and pre-operative weight change are different targets and may justify different risk.
During the visit
Ask the clinician to name each drug, the starting dose, and the reason it is in your plan. Then ask which drug they would drop first if you felt unwell. If the answer is “we always keep the full stack,” consider a second opinion.
Ask how they would treat pain after dental work or an injury while naltrexone is on board. Ask how they monitor cognitive change if topiramate is included. Ask what GI symptoms would pause metformin. Those three questions expose whether the plan is individualized.
After the first weeks
Keep a short log: appetite, bowel changes, attention at work, mood, and hydration. Bring the log to the first follow-up. Combination side effects are easy to dismiss one by one and easier to see on paper.
If a dose increase is proposed, ask what problem the increase is solving. “The scale is slow” is not always a reason to add burden. Sometimes food structure and sleep are the missing pieces.
Red flags in a vendor
Be cautious if a program ships a three-drug combination after a two-minute quiz, will not name the pharmacy, or discourages you from telling your primary-care clinician. Be cautious if they imply the combination is universally safer than a GLP-1-class drug or universally stronger. Those claims skip the person in front of them.
Also be cautious if refill messages arrive faster than follow-up messages. A combination protocol is maintenance work, not a subscription box.
Decide with an off-switch
Set a review date before you start. On that date, you and the clinician should be able to say continue, simplify, or stop. Simplifying is a success if you keep the tolerated piece and drop the rest. Stopping is a success if the burden was too high.
Combination metabolic therapy is a set of tools with overlapping side effects. The checklist is there to keep the conversation specific. Names on a product page are only useful when they lead to a written plan you can understand and discontinue.
Keep your primary-care clinician in the loop
Send a one-page summary after the first visit: drugs, doses, pharmacy, and the review date. Primary-care teams catch kidney changes and new diagnoses that a specialty portal may not see the same week.
If the specialty clinic objects to that share, that is information. Combination metabolic therapy is still ordinary medicine. Ordinary medicine is shareable with the clinicians who already know your chart.
Use the review date even if you feel fine. Feeling fine is not the same as a plan that still fits. The checklist exists so you do not discover the mismatch only after a refill reminder.
